Chunxiao Zhou - Concepedia

Author

Chunxiao Zhou

University of North Carolina at Chapel Hill ORCID

Also Known As

Bae-Jump, Victoria, Bae-Jump, Victoria L, Bae-Jump, Victoria L., Barroilhet, Lisa, Boggess, John F., C-C. Zhou, C. Zhou, C., Zhou, Cantrell, Leigh A., Chaoqing Zhou

265

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Shandong First Medical University Beijing Obstetrics and Gynecology Hospital Shandong Tumor Hospital Capital Medical University

About

Chunxiao Zhou is an author at University of North Carolina at Chapel Hill specializing in medicine, obstetrics, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	1.8K
2	Engineering	4	4	321
3	Natural Sciences	2	2	65
4	Health Sciences	1	1	13
5	Public Health	1	1	11

Chunxiao Zhou

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy Leigh A. Cantrell, Chunxiao Zhou, Alberto A. Mendivil, Gynecologic Oncology OncologyNovel Treatment StrategyPotent InhibitorMedicineCancer Cell Biology	2009	329
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling Jianjun Han, Lu Zhang, Hui Guo, Gynecologic Oncology Glucose PromotesSignaling PathwayMedicineReceptor Tyrosine KinaseGynecology	2015	181
Phytosomes Loaded with Mitomycin C–Soybean Phosphatidylcholine Complex Developed for Drug Delivery Zhenqing Hou, Li Yang, Yuancan Huang, Molecular Pharmaceutics Cell-based Drug DeliveryNanomedicineLipid PreparationDrug TargetingMmc-loaded Phytosomes	2012	173
Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway Rabbie K. Hanna, Chunxiao Zhou, Kimberly Malloy, Gynecologic Oncology MedicinePharmacologyGynecologyCell ProliferationMtor Pathway	2012	146
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway Lingqin Yuan, Xiugui Sheng, Adam K. Willson, Endocrine Related Cancer Glutamine MetabolismOncologyBiochemistryOncogenic AgentMedicine	2015	107
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer* Haifeng Qiu, Amanda Jackson, Joshua E. Kilgore, Oncotarget	2015	94
Biomimetic, dopamine-modified superhydrophobic cotton fabric for oil–water separation Xiaojie Yan, Xiaowei Zhu, Yuting Ruan, Cellulose Chemical EngineeringEngineeringSuper-hydrophobic SurfaceWater PurificationOil–water Separation	2020	91
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer J.E. Stine, Hui Guo, Xiugui Sheng, Oncotarget	2015	90
Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis Aaron Shafer, Chunxiao Zhou, Paola A. Gehrig, International Journal of Cancer Chemoprevention StrategyMedicinePharmacologyGynecologyCell Death	2009	81
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer M. Schointuch, Timothy P. Gilliam, J.E. Stine, Gynecologic Oncology Anti-tumorigenic EffectsMedicinePharmacologyGynecologyCancer Biology	2014	77

Page 1